Gynecologic cancer is the growth and spread of cancer cells in the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva as well as in peritoneum—also known as the reproductive organs, which make any woman at risk ...
Sep 8, 2021
0
3
Cancer cells sometimes develop resistance to the cytotoxic drugs used in chemotherapy. Figuring out why the treatment isn't working and why it may even defeat its own purpose is therefore important to understand.
Aug 5, 2021
0
296
Using advanced imaging technology, Mayo Clinic scientists have provided an unprecedented understanding of the BRCA1-BARD1 protein complex, which is often mutated in patients with breast or ovarian cancer. Their paper, published ...
Jul 28, 2021
0
297
(Healthday News)—Johnson & Johnson is being sued by the National Council of Negro Women (NCNW) over the company's marketing of baby powder to Black women.
Jul 28, 2021
0
2
A test being developed in Queensland could help to reduce the high mortality rate from ovarian cancer by dramatically improving the accuracy of early detection.
Jul 26, 2021
0
2
Survival rates for adolescents and young adults diagnosed with cancer have varied considerably depending on cancer type. A new study indicates that survival for multiple cancer types in such patients has improved in recent ...
Jul 26, 2021
0
2
Researchers at Texas A&M University are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer. A team has recently submitted a patent disclosure ...
Jul 23, 2021
0
800
A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic ...
Jul 23, 2021
0
9
(HealthDay)—Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers, according to a study published in the July issue of the American Journal of Obstetrics & Gynecology.
Jul 7, 2021
0
1
Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant ...
Jun 11, 2021
0
2
